SCHEMBL25342803

SCHEMBL25342803

COc1ncc(Br)c(C=O)c1Br

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 2/20 0.41
▸ PRKDC P78527 1/20 0.39
▸ S100A9 P06702 4/20 0.34
▸ CCR4 P51679 9/20 0.33
▸ LMNA P02545 2/20 0.33
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ CCR5 P51681 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18613842 0.84 PRKDC (0.38) ERN1PRKDCS100A9CCR4LMNA
SCHEMBL31087530 0.75 LMNA (0.41) ERN1PRKDCLMNAALDH1A1HPGD
SCHEMBL22542733 0.75 LMNA (0.41) ERN1PRKDCLMNAALDH1A1HPGD
SCHEMBL25344432 0.73 CA1 (0.46) CA12CA1CA2CA9MAPT
SCHEMBL21634877 0.72 GAA (0.32) CA2MAPT
SCHEMBL25335302 0.71 PRKDC (0.37) ERN1PRKDCS100A9CCR4LMNA
SCHEMBL22448808 0.71 ALOX5 (0.35) ERN1CA2ALDH1A1MAPT
SCHEMBL14853026 0.71 MAPT (0.39) CA2ALDH1A1MAPTHPGDL3MBTL1
SCHEMBL1369023 0.70 ALDH1A1 (0.43) PRKDCS100A9LMNAALDH1A1MAPT
SCHEMBL29723697 0.70 ALDH1A1 (0.43) PRKDCS100A9LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 — — EP disclosed
WO-2023205463-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 — — WO disclosed
Send feedback